Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Waltering KK et al. – The results show that overexpression of AR sensitizes castration–resistant prostate cancer cells to the low levels of androgens. The activity of AR signaling pathway is regulated by the levels of both ligand and the receptor.

Related Articles

Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
The Lancet Oncology, 10/01/09    Relevance Score: 71%

C/EBP redirects androgen receptor signaling through a unique bimodal interaction
Oncogene, 11/12/09    Relevance Score: 67%

Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09    Relevance Score: 67%

Complete androgen insensitivity syndrome: diagnosis and management
Expert Review of Endocrinology & Metabolism, 11/17/09    Relevance Score: 66%

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
British Journal of Cancer, 11/06/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address